• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Deninger Paul F was granted 7,887 shares, increasing direct ownership by 12% to 74,826 units (SEC Form 4)

    6/6/25 6:01:59 PM ET
    $REZI
    Wholesale Distributors
    Industrials
    Get the next $REZI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    DENINGER PAUL F

    (Last) (First) (Middle)
    16100 N 71ST STREET
    SUITE 550

    (Street)
    SCOTTSDALE AZ 85254

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    RESIDEO TECHNOLOGIES, INC. [ REZI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/04/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/04/2025 A 7,887 A $0 74,826 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    /s/ Jeannine J. Lane, as Attorney-in-Fact for Paul F. Deninger 06/06/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $REZI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $REZI

    DatePrice TargetRatingAnalyst
    4/22/2025$16.00Overweight → Neutral
    Analyst
    8/9/2024$25.00Outperform
    Evercore ISI
    7/5/2023$22.00Overweight
    JP Morgan
    11/2/2022$27.00Outperform → In-line
    Imperial Capital
    2/16/2022$31.00 → $30.00Equal-Weight
    Morgan Stanley
    10/6/2021$33.00 → $31.00Equal-Weight
    Morgan Stanley
    9/21/2021$36.00 → $33.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $REZI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Resideo Announces First Quarter 2025 Financial Results; Reaffirms 2025 Outlook

      Net revenue was $1.77 billion, up 19% year-over-year, at the high-end of outlook range; reflects mid-single-digit organic revenue(1) growth at both ADI and Products and Solutions Total company gross margin was 28.9%, up 200 basis points year-over-year; Products and Solutions gross margin was 41.4%, eighth consecutive quarter of year-over-year improvementThe integration of Snap One into ADI is progressing well and synergy achievement is ahead of planOver 98% of product costs incurred by the Products and Solutions segment in Mexico are currently exempt from tariffsSCOTTSDALE, Ariz., May 6, 2025 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE:REZI), a leading global manufacturer, developer, an

      5/6/25 4:05:00 PM ET
      $REZI
      Wholesale Distributors
      Industrials
    • Resideo To Participate at Upcoming Investor Conferences

      SCOTTSDALE, Ariz., May 5, 2025 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE:REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets, today announced that it is scheduled to participate at the following investor conferences. Oppenheimer 20th Annual Industrial Growth Conference held virtually on Wednesday, May 7, 2025. Michael Carlet, Resideo's Chief Financial Officer, and Thomas Surran, President of Resideo's Products & Solutions business segment, will partic

      5/5/25 4:05:00 PM ET
      $REZI
      Wholesale Distributors
      Industrials
    • Resideo to Release First Quarter 2025 Financial Results on May 6, 2025

      SCOTTSDALE, Ariz., April 15, 2025 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE:REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets, will release first quarter 2025 financial results after the close of the New York Stock Exchange on Tuesday, May 6, 2025. A conference call and simultaneous webcast to discuss the results will be held on Tuesday, May 6, 2025 at 5:00 p.m. ET. Interested investors and other parties can listen to a webcast of the conference cal

      4/15/25 4:05:00 PM ET
      $REZI
      Wholesale Distributors
      Industrials